Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates

This publication has 31 references indexed in Scilit:

• Failure of a Mycobacterium tuberculosis ΔRD1 ΔpanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: Comparisons to responses elicited by M. bovis bacille Calmette Guerin
  Vaccine, 2007
• Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis
  Journal of Clinical Investigation, 2007
• Evaluation of a novel vaccine (HVJ–liposome/HSP65 DNA + IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB
  Vaccine, 2007
• Early Events in Mycobacterium tuberculosis Infection in Cynomolgus Macaques
  Infection and Immunity, 2006
• Mycobacterium tuberculosis ΔRD1 ΔpanCD: A safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis
  Vaccine, 2006
• Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
  The Lancet, 2006
• A review of vaccine research and development: Tuberculosis
  Vaccine, 2005
• New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development
  Vaccine, 2005
• Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
  Vaccine, 2004
• Development of Vγ2Vδ2⁺T Cell Responses during Active Mycobacterial Coinfection of Simian Immunodeficiency Virus–Infected Macaques Requires Control of Viral Infection and Immune Competence of CD4⁺T Cells
  The Journal of Infectious Diseases, 2004